yt:channel:UCWSaKrMCpVw1xrNeLOweZ1w UCWSaKrMCpVw1xrNeLOweZ1w Ablynx ABLX https://www.youtube.com/channel/UCWSaKrMCpVw1xrNeLOweZ1w 2013-07-10T14:42:05+00:00 yt:video:A2kzdfjU6fU A2kzdfjU6fU UCWSaKrMCpVw1xrNeLOweZ1w Ablynx ABLX https://www.youtube.com/channel/UCWSaKrMCpVw1xrNeLOweZ1w 2013-07-11T14:02:09+00:00 2017-06-30T17:50:14+00:00 All you want to know about Ablynx's Nanobodies Nanobodies are antibody-derived therapeutic proteins that contain the unique structural and functional properties of naturally-occurring heavy-chain antibodies. The Nanobody technology was originally developed following the discovery that camelidae (camels and llamas) possess fully functional antibodies that lack light chains. These heavy-chain antibodies contain a single variable domain (VHH) and two constant domains (CH2 and CH3). Importantly, the cloned and isolated VHH domain is a perfectly stable polypeptide harbouring the full antigen-binding capacity of the original heavy-chain antibody. These newly discovered VHH domains with their unique structural and functional properties form the basis of a new generation of therapeutic antibodies which Ablynx has named Nanobodies. yt:video:PnxDeQtQBYU PnxDeQtQBYU UCWSaKrMCpVw1xrNeLOweZ1w Ablynx ABLX https://www.youtube.com/channel/UCWSaKrMCpVw1xrNeLOweZ1w 2013-07-11T13:57:54+00:00 2015-11-08T15:14:32+00:00 Ablynx received Trends Gazellen 2012 award Ablynx received the award "Trends Gazellen 2012 ambassador" as fastest growing company in East Flanders in the category 'midsized companies'.